Clinical and genetic determinants of coronary stent thrombosis in patients on dual antiplatelet therapy

被引：0
|
作者：
Cayla, G. [1 ]
Hulot, J. S. [2 ]
Silvain, J. [1 ]
Pattack, A. [3 ]
Gruel, Y. [4 ]
Huerre, Y. [5 ]
Allanic, F. [2 ]
O'Connor, S. [1 ]
Montalescot, G. [1 ]
Collet, J. P. [1 ]
机构：
[1] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Inst Cardiol,INSERM,CMR937, Paris, France
[2] Univ Paris 06, INSERM, UMR S956, Paris, France
[3] Univ Hosp Toulouse Rangueil Hosp, Toulouse, France
[4] Hosp Trousseau, Tours Reg Univ Hosp, Dept Cardiol, Tours, France
[5] Hosp Arnaud de Villeneuve, Montpellier, France
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [21] Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery
    Motovska, Zuzana
    DRUGS, 2011, 71 (14) : 1797 - 1806
  • [22] Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery
    Zuzana Motovska
    Drugs, 2011, 71 : 1797 - 1806
  • [23] Optimalized individual antiplatelet therapy in high risk cardiovascular patients with coronary stent thrombosis and clopidogrel resistance
    Zsamboki, E. Toth
    Beres, B. J.
    Vargova, K.
    Bencze, J.
    Kerecsen, G.
    Csoti, E.
    Preda, I.
    Kiss, R. G.
    EUROPEAN HEART JOURNAL, 2006, 27 : 752 - 752
  • [24] Continuation of Dual Antiplatelet Therapy in a Patient with a Coronary Artery Stent with Dengue Hemorrhagic Fever: A Clinical Conundrum
    Ehelepola, N. D. B.
    Athurupana, A. A. S. D.
    Bowatte, P. G. C. S.
    Dissanayake, Wasantha P.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 102 (01): : 17 - 19
  • [25] Intraoperative Thrombosis of Right Coronary Artery Drug-Eluting Stent After 2 Years of Dual Antiplatelet Therapy
    Murray, Aaron T.
    Sederberg, James H., II
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2011, 15 (1-2) : 40 - 43
  • [26] Influence of resistance to dual antiplatelet therapy on subacute stent thrombosis after primary percutaneus intervention for acute coronary syndrome
    Pregowski, Jerzy
    Sitkiewicz, Dariusz
    Przyluski, Jakub
    Kalinczuk, Lukasz
    Janas, Jadwiga
    Witkowski, Adam
    Kruk, Mariusz
    Ruzyllo, Witold
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 203M - 203M
  • [27] Antiplatelet therapy in the era of late stent thrombosis
    Nair R.
    Simon D.I.
    Current Treatment Options in Cardiovascular Medicine, 2008, 10 (1) : 12 - 17
  • [28] Antiplatelet therapy and prognosis at the onset of stent thrombosis
    Matsuoka, Y.
    Sotomi, Y.
    Hikoso, S.
    Nakatani, D.
    Okada, K.
    Dohi, T.
    Kida, H.
    Sunaga, A.
    Tsujimura, T.
    Kikuchi, A.
    Tanaka, A.
    Kosugi, S.
    Ichibori, Y.
    Ishihara, T.
    Sakata, Y.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [29] D-dimer as a potential novel thrombus biomarker for predict stent thrombosis in patients on dual antiplatelet therapy after percutaneous coronary intervention
    Zhao, X.
    Li, J.
    Li, J.
    Li, Y.
    Yang, Y.
    Gao, R.
    Xu, B.
    Yuan, J.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1281 - 1281
  • [30] Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents Insights From the Xience V Coronary Stent System Trials
    Genereux, Philippe
    Rutledge, David R.
    Palmerini, Tullio
    Caixeta, Adriano
    Kedhi, Elvin
    Hermiller, James B.
    Wang, Jin
    Krucoff, Mitchell W.
    Jones-McMeans, Jennifer
    Sudhir, Krishnankutty
    Simonton, Charles A.
    Serruys, Patrick W.
    Stone, Gregg W.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (05)
12345